Granisetron Market Share

Statistics for the 2023 & 2024 Granisetron market share, created by Mordor Intelligence™ Industry Reports. Granisetron share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Granisetron Industry

The granisetron market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. Some of the major players in the market are Kyowo Kirin Co. Ltd, Heron Therapeutics, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals, and Viatris. The key market players are strategically involved in various activities, such as product launches, collaborations, and expansions, in order to improve their product portfolio.

Granisetron Market Leaders

  1. Kyowa Kirin Co., Ltd.

  2. Heron Therapeutics, Inc.

  3. Viatris

  4. Hikma Pharmaceuticals PLC

  5. Fresenius SE & Co. KGaA

*Disclaimer: Major Players sorted in no particular order

Granisetron Market Concentration

Granisetron Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)